Delivery Order SPE2DR25D2014-SPE2DR26FZ73G
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,499.42 to AmerisourceBergen Drug Corp for TALTZ 80 mg/mL autoinjector on November 12, 2025, with completion scheduled for November 13, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an open procurement process. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml auto-injector (2-pack) with a ceiling value of $12,433.02 under a firm fixed-price contract type. The award was made on October 30, 2025, with an ultimate completion date of October 31, 2025, and no set-aside designation was utilized. Performance will take place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,399.82 for TALTZ 80 MG/ML AutoInjector on September 17, 2025, with completion scheduled for September 18, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. The place of performance is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,408.43 for TALTZ 80 MG/ML AutoInjector on October 29, 2025, with an ultimate completion date of October 30, 2025. This firm fixed price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion pharmaceutical prime vendor agreement running through December 2026. The delivery...
- The Defense Logistics Agency awarded a $26,229.86 delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml auto-injectors, with an ultimate completion date of November 17, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively on November 14, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a prescription biologic medication used to treat inflammatory...
- The Defense Logistics Agency awarded a $4,580.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/mL autoinjectors, with an ultimate completion date of October 30, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The product will be supplied to the place of...
- The Defense Logistics Agency (DLA) awarded a $31,833.56 delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/mL auto-injector (2-pack) pharmaceutical products, with an ultimate completion date of July 31, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a $39,167.67 delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml auto-injector (2-pack) pharmaceutical products on October 22, 2025, with completion targeted for October 23, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded procurement supporting federal medical supply requirements. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $13,270.91 to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of TALTZ 80 mg/ml autoinjector medication. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, with an ultimate completion date of November 18, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $8,894.37 to AmerisourceBergen Drug Corp for TALTZ 80 MG/ML Autoinjector on August 25, 2025, with completion scheduled for August 26, 2025. This competitive award, utilizing firm fixed pricing with no set-aside designation, represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to the company's corporate office...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FZ73GDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/mL auto-injector (2-pack) pharmaceutical supplies, valued at $12,756.05 under a firm fixed price contract structure. This non-competitive delivery order, issued on November 17, 2025, with an ultimate completion date of November 18, 2025, represents a direct fulfillment action against AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate facility in Conshohocken, Pennsylvania, the company's headquarters and primary distribution center for federal pharmaceutical procurement. This delivery order is executed under AmerisourceBergen's prime indefinite delivery contract SPE2DX with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The SPE2DX contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to military healthcare programs and the Defense Health Agency. TALTZ (ixekizumab) is a specialty biologic medication, and this order reflects the ongoing demand for pharmaceutical commodities through DLA's centralized medical supply chain supporting defense and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.8k | 11/17/25 |